Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.
…, D Garrison, C Kuo, LJ Foshag, AJ Nizze… - Journal of clinical …, 1995 - ascopubs.org
PURPOSE The objective of the study was to develop a sensitive multimarker polymerase
chain reaction (PCR) assay to detect circulating melanoma cells in patient blood. The rationale …
chain reaction (PCR) assay to detect circulating melanoma cells in patient blood. The rationale …
[HTML][HTML] Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy
…, SKS Huang, DSB Hoon, RF Irie, AJ Nizze… - Journal of investigative …, 1998 - Elsevier
Several melanosome glycoproteins have been shown to be antigenic in humans. Correlation
of antigen-specific immune responses in patients with the autoimmune disease vitiligo, …
of antigen-specific immune responses in patients with the autoimmune disease vitiligo, …
Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne …
DL Morton, L Wanek, JA Nizze, RM Elashoff… - Annals of …, 1991 - ncbi.nlm.nih.gov
A review of 1134 patients from the John Wayne Cancer Clinic with melanoma metastatic to
regional lymph nodes was carried out to evaluate the importance of various prognostic …
regional lymph nodes was carried out to evaluate the importance of various prognostic …
Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamide
DSB Hoon, LJ Foshag, AS Nizze, R Bohman… - Cancer research, 1990 - AACR
Previous studies have shown that melanoma patients develop an immune response to cell
surface melanoma-associated antigens. The presence of this antibody response to cell …
surface melanoma-associated antigens. The presence of this antibody response to cell …
Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine
…, LJ FOSHAG, DSB HOON, JA NIZZE… - Annals of …, 1992 - journals.lww.com
A new polyvalent melanoma cell vaccine (MCV) was administered to 136 stage. IIIA and IV (American
Joint Committee on Cancer) melanoma patients. Induction of cell-mediated and …
Joint Committee on Cancer) melanoma patients. Induction of cell-mediated and …
Magnetic‐induction hyperthermia. Results of a 5‐year multi‐institutional national cooperative trial in advanced cancer patients
…, JW Thomson, JD Khandekar, D Roe, A Nizze… - Cancer, 1985 - Wiley Online Library
Nine US institutions performed 14,807 Phase I‐II treatments of magnetic‐induction (Magnetrode
[Henry Medical Electronics, Inc., Los Angeles, CA]) hyperthermia in 1170 adults. All had …
[Henry Medical Electronics, Inc., Los Angeles, CA]) hyperthermia in 1170 adults. All had …
Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to …
…, DSB Hoon, M Ravindranath, JA Nizze… - Annals of …, 2002 - journals.lww.com
Objective To determine whether adjuvant postoperative active specific immunotherapy with
a therapeutic polyvalent vaccine (PV) called Canvaxin can prolong survival following …
a therapeutic polyvalent vaccine (PV) called Canvaxin can prolong survival following …
Is the survival of melanoma patients receiving polyvalent melanoma cell vaccine linked to the human leukocyte antigen phenotype of patients?
…, T Okamoto, HJ Wang, R Elashoff, AJ Nizze… - Journal of clinical …, 1998 - ascopubs.org
PURPOSE An allogeneic polyvalent melanoma cell vaccine (PMCV) has been shown to be
efficacious in improving overall survival of patients with malignant melanoma in a phase II …
efficacious in improving overall survival of patients with malignant melanoma in a phase II …
Prognostic significance of pregnancy in stage I melanoma
JH Wong, EE Sterns, KH Kopald, JA Nizze… - Archives of …, 1989 - jamanetwork.com
• The clinical course of 66 patients with stage I melanoma, diagnosed during pregnancy,
treated in the Division of Surgical Oncology at UCLA, was retrospectively reviewed. These …
treated in the Division of Surgical Oncology at UCLA, was retrospectively reviewed. These …
[PDF][PDF] Detection of malignant melanoma with iodine-123 iodoamphetamine
…, RR Lake, L Cagle, LS Graham, A Nizze… - Journal of nuclear …, 1988 - Soc Nuclear Med
RESULTS A preliminary experiment was designed to test IMP incorporation by pigmented
and nonmelanotic mela noma cell lines compared with several controls. Equal numbers of the …
and nonmelanotic mela noma cell lines compared with several controls. Equal numbers of the …